Economic value of diastasis repair with the use of mesh compared to no intervention in Italy.
TL;DR
Clinical and economic evidence is provided to help improving the decision-making process and allocating scarce resources between competing ends for minimally invasive RAD repair through cost-effectiveness and budget impact analyses from both National Healthcare Service and societal perspectives in Italy.
OpenAlex 토픽 ·
Cardiac, Anesthesia and Surgical Outcomes
Health Systems, Economic Evaluations, Quality of Life
Hernia repair and management
Clinical and economic evidence is provided to help improving the decision-making process and allocating scarce resources between competing ends for minimally invasive RAD repair through cost-effective
APA
Carla Rognoni, A. Carrara, et al. (2024). Economic value of diastasis repair with the use of mesh compared to no intervention in Italy.. The European journal of health economics : HEPAC : health economics in prevention and care, 25(9), 1569-1580. https://doi.org/10.1007/s10198-024-01685-z
MLA
Carla Rognoni, et al.. "Economic value of diastasis repair with the use of mesh compared to no intervention in Italy.." The European journal of health economics : HEPAC : health economics in prevention and care, vol. 25, no. 9, 2024, pp. 1569-1580.
PMID
38480616
Abstract
[AIM] Rectus abdominal diastasis (RAD) can cause mainly incontinence and lower-back pain. Despite its high incidence, there is no consensus regarding surgical indication. We aimed at comparing RAD repair (minimally invasive technique with mesh implant) with no treatment (standard of care - SOC) through cost-effectiveness and budget impact analyses from both National Healthcare Service (NHS) and societal perspectives in Italy.
[METHODS] A model was developed including social costs and productivity losses derived by the online administration of a socio-economic questionnaire, including the EuroQol for the assessment of quality of life. Costs for the NHS were based on reimbursement tariffs.
[RESULTS] Over a lifetime horizon, estimated costs were 64,115€ for SOC and 46,541€ for RAD repair in the societal perspective; QALYs were 19.55 and 25.75 for the two groups, respectively. Considering the NHS perspective, RAD repair showed an additional cost per patient of 5,104€ compared to SOC, leading to an ICUR of 824€. RAD repair may be either cost-saving or cost-effective compared to SOC depending on the perspective considered. Considering a current scenario of 100% SOC, an increased diffusion of RAD repair from 2 to 10% in the next 5 years would lead to an incremental cost of 184,147,624€ for the whole society (87% borne by the NHS) and to incremental 16,155 QALYs.
[CONCLUSION] In light of the lack of economic evaluations for minimally invasive RAD repair, the present study provides relevant clinical and economic evidence to help improving the decision-making process and allocating scarce resources between competing ends.
[METHODS] A model was developed including social costs and productivity losses derived by the online administration of a socio-economic questionnaire, including the EuroQol for the assessment of quality of life. Costs for the NHS were based on reimbursement tariffs.
[RESULTS] Over a lifetime horizon, estimated costs were 64,115€ for SOC and 46,541€ for RAD repair in the societal perspective; QALYs were 19.55 and 25.75 for the two groups, respectively. Considering the NHS perspective, RAD repair showed an additional cost per patient of 5,104€ compared to SOC, leading to an ICUR of 824€. RAD repair may be either cost-saving or cost-effective compared to SOC depending on the perspective considered. Considering a current scenario of 100% SOC, an increased diffusion of RAD repair from 2 to 10% in the next 5 years would lead to an incremental cost of 184,147,624€ for the whole society (87% borne by the NHS) and to incremental 16,155 QALYs.
[CONCLUSION] In light of the lack of economic evaluations for minimally invasive RAD repair, the present study provides relevant clinical and economic evidence to help improving the decision-making process and allocating scarce resources between competing ends.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 합병증 | lower-back
|
scispacy | 1 | ||
| 약물 | NHS
→ National Healthcare Service
|
scispacy | 1 | ||
| 약물 | 824€.
|
scispacy | 1 | ||
| 질환 | incontinence
|
C0021167
Incontinence
|
scispacy | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | NHS
→ National Healthcare Service
|
scispacy | 1 |
MeSH Terms
Humans; Italy; Surgical Mesh; Cost-Benefit Analysis; Quality-Adjusted Life Years; Male; Female; Rectus Abdominis; State Medicine; Middle Aged; Quality of Life; Aged
같은 제1저자의 인용 많은 논문 (2)
- Cost-Benefit Analysis of Trans-Arterial Radio-Embolization with Y-90 Glass Microspheres Versus Drug-Eluting Bead Trans-Arterial Chemo-Embolization in Patients with Hepatocellular Carcinoma in Italy.
- Early budget impact analysis of magnetic balloon technology for facilitating the completion of difficult colonoscopies.